Skip to main content
< Back
About
About the conference
Organisers & Partners
Registration
App
Podcast
Early Career Researchers
Call for abstracts
Guidelines
Latest updates
Press room
Venue
Programme
Full programme
Programme outline
Tracks
Speakers
All speakers
Keynote speakers
Side events
Subscribe
Programme
Keywords
Africa
Alcohol
Asia
Basic research
Behavioural addictions
Cannabis
Capacity-building
Civil society
Clinical research/practice
Comorbidity
COVID-19
Criminal justice/prisons
Criminology
Drug user's perspectives
E-health/digitalisation
ECR (Early Career Researchers)
Europe
Gender perspectives
Harm reduction
Health inequalities
Hepatitis
HIV
Infectious diseases
Markets
Mental health and wellbeing
Monitoring and evaluation
Neuroscience
New psychoactive substances
Nicotine/tobacco
North America
Oceania
Opiates
Overdose
Policy
Prescription drugs
Prevention
Psychostimulants
Public health
Qualitative methods
Quantitative methods
Recreational setting
Risky behaviours
South America
Toxicology and forensic analysis
Treatment
Underrepresented groups
Workforce
Youth/children
- Any -
WED
23 OCT
THU
24 OCT
FRI
25 OCT
All
Plenary session
Big debate
Major session
Workshop
Oral presentation session
Short communication session
e-short communication session
e-poster session
Video contest
PDF version
Wed 23 Oct
10:00
e-poster session day 1
10:00
to
19:20
Digital kiosks
e-poster session
11:50
Sex, gender and diversity in drugs
11:50
to
13:20
Auditorium IV
Oral presentation session
Advancing addiction research: global perspectives and collaborative initiatives
11:50
to
13:20
Auditorium VI
Oral presentation session
Lives at risk: mental health and substance use
11:50
to
13:20
Auditorium VII
Oral presentation session
Prevalence of opioids and related harms
11:50
to
13:20
Auditorium VIII
Oral presentation session
Mechanisms and outcomes in substance use prevention among youth
11:50
to
13:20
Room 5A
Oral presentation session
Building addiction workforce capacity
11:50
to
13:20
Room 5C
Oral presentation session
Evaluation of drug consumption rooms: guidance step by step
11:50
to
13:20
Room 1.15
Workshop
14:20
Enhancing access to harm reduction services in community and prisons: experiences of translating policy into practice and scaling interventions
14:20
to
15:50
Auditorium I
Major session
Drug policy and the criminal legal system
14:20
to
15:50
Auditorium VI
Oral presentation session
Challenge of measuring use and impact of cannabinoids
14:20
to
15:50
Room 1.07
Oral presentation session
Methods and measurement
14:20
to
15:50
Room 1.08
Short communication session
The peer model: the critical role of ethics in efficacy
14:20
to
15:50
Room 1.15
Workshop
16:00
Challenges in community-based prevention
16:00
to
17:30
Auditorium I
Major session
The recovery journey
16:00
to
17:30
Auditorium III
Oral presentation session
Infectious diseases in people who inject drugs
16:00
to
17:30
Auditorium IV
Oral presentation session
Measuring drug market phenomenon
16:00
to
17:30
Auditorium VI
Oral presentation session
Surveillance of drug-related morbidity and mortality
16:00
to
17:30
Room 5A
Oral presentation session
Inequalities and needs of migrant groups
16:00
to
17:30
Room 5C
Oral presentation session
Quality in addictions work systems
16:00
to
17:30
Room 1.06
Oral presentation session
Problematic gambling and gaming
16:00
to
17:30
Room 1.07
Short communication session
Conceptualising health and harms
16:00
to
17:30
Room 1.08
Short communication session
17:50
Drug use trends
17:50
to
19:20
Auditorium IV
Oral presentation session
Psychedelics 1
17:50
to
19:20
Auditorium VIII
Oral presentation session
Novel and contextual approaches in prevention
17:50
to
19:20
Room 5A
Oral presentation session
Opioid treatment 1
17:50
to
19:20
Room 5B
Oral presentation session
Motivations for use
17:50
to
19:20
Room 5C
Oral presentation session
Hepatitis C, HIV, and other drug related harms
17:50
to
19:20
Room 1.05
Short communication session
Opioids: trends, use and treatments
17:50
to
19:20
Room 1.06
Short communication session
19:30
Why are we not doing better at reducing drug-related deaths?
19:30
to
20:30
Auditorium I
Big debate
Thu 24 Oct
11:50
Opioid Agonist Treatment: novel formulations and challenges
11:50
to
13:20
Auditorium IV
Oral presentation session
Evidence informed drug and alcohol policy
11:50
to
13:20
Auditorium VI
Oral presentation session
Emerging drug harms, DCRs and other responses
11:50
to
13:20
Auditorium VII
Short communication session
Innovative methods for understanding drug markets and policy
11:50
to
13:20
Room 5A
Oral presentation session
Workers reaching marginalised groups
11:50
to
13:20
Room 5C
Oral presentation session
Contemporary issues
11:50
to
13:20
Room 1.08
Oral presentation session
Back-casting exercise on peer-support workforce development
11:50
to
13:20
Room 1.15
Workshop
14:20
Understanding drug-related deaths
14:20
to
15:50
Auditorium IV
Oral presentation session
Conceptual frameworks for studying drug policy
14:20
to
15:50
Auditorium VI
Oral presentation session
Young people, mental health and substance use
14:20
to
15:50
Auditorium VII
Oral presentation session
Co-creating robust systems with workers
14:20
to
15:50
Room 5C
Oral presentation session
Understanding harm reduction: economic, social, and health perspectives
14:20
to
15:50
Room 1.05
Short communication session
Women's realities of drug use
14:20
to
15:50
Room 1.08
Oral presentation session
16:00
Hepatitis C testing and treatment
16:00
to
17:30
Auditorium IV
Oral presentation session
From genes to brains
16:00
to
17:30
Room 1.06
Short communication session
City insights: creating a collaborative network for city-level monitoring of drug trends and harm reduction
16:00
to
17:30
Room 1.07
Workshop
17:50
Mixed methods for understanding drug use
17:50
to
19:20
Auditorium III
Oral presentation session
Substance use and mental health in treatment settings
17:50
to
19:20
Auditorium VII
Oral presentation session
Misuse of medicines
17:50
to
19:20
Auditorium VIII
Oral presentation session
From old to new: changes in drug use
17:50
to
19:20
Room 5C
Oral presentation session
Fri 25 Oct
11:50
Intentional and non-intentional drug-related deaths
11:50
to
13:20
Auditorium IV
Oral presentation session
Psychedelics 2
11:50
to
13:20
Auditorium VI
Oral presentation session
Drugs checking services
11:50
to
13:20
Room 5A
Oral presentation session
Online monitoring
11:50
to
13:20
Room 5B
Oral presentation session
Emerging challenges in drug markets: monitoring, measurement & impacts
11:50
to
13:20
Room 1.05
Short communication session
Gaming and health
11:50
to
13:20
Room 1.06
Short communication session
Support for the addiction workforce
11:50
to
13:20
Room 1.07
Oral presentation session
14:20
Young people and drugs
14:20
to
15:50
Auditorium III
Oral presentation session
Overdose prevention
14:20
to
15:50
Auditorium IV
Oral presentation session
Holistic care for mental well-being
14:20
to
15:50
Room 1.05
Short communication session
MENU
Back
EUROPE POC
My profile
Notifications
My favourites
Scan contacts
My contacts
Settings